← Back to headlines
Greek Pharmacists Highlight Delays in Access to Innovative Medicines
Greek pharmacists are drawing attention to significant delays in patient access to new innovative drugs, noting that only 42 out of 214 EMA-approved medications are currently available, with an average waiting time of nearly two years.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
